Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
15.91
+0.12 (0.76%)
At close: Dec 18, 2025, 4:00 PM EST
16.03
+0.12 (0.75%)
Pre-market: Dec 19, 2025, 8:00 AM EST
Aurinia Pharmaceuticals Market Cap
Aurinia Pharmaceuticals has a market cap or net worth of $2.1 billion as of December 19, 2025. Its market cap has increased by 65.54% in one year.
Market Cap
2.10B
Enterprise Value
1.82B
1-Year Change
65.54%
Ranking
Category
Stock Price
$15.91
Market Cap Chart
Since September 3, 2014, Aurinia Pharmaceuticals's market cap has increased from $125.50M to $2.10B, an increase of 1,571.38%. That is a compound annual growth rate of 28.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 2.10B | 63.15% |
| Dec 31, 2024 | 1.29B | -0.41% |
| Dec 29, 2023 | 1.29B | 110.29% |
| Dec 30, 2022 | 613.90M | -79.30% |
| Dec 31, 2021 | 2.97B | 69.58% |
| Dec 31, 2020 | 1.75B | -8.45% |
| Dec 31, 2019 | 1.91B | 233.25% |
| Dec 31, 2018 | 573.20M | 50.68% |
| Dec 29, 2017 | 380.40M | 366.75% |
| Dec 30, 2016 | 81.50M | 3.69% |
| Dec 31, 2015 | 78.60M | -31.17% |
| Dec 31, 2014 | 114.20M | -9.00% |
| Sep 3, 2014 | 125.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 950.72B |
| Johnson & Johnson | 503.35B |
| AbbVie | 396.14B |
| UnitedHealth Group | 295.69B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 250.66B |
| Abbott Laboratories | 217.43B |